Covid-19 Vaccine's Development Won't Be Affected by Politics, Pfizer CEO Says
October 01 2020 - 3:51PM
Dow Jones News
By Jared S. Hopkins
Pfizer Inc.'s chief executive sought to assure the drugmaker's
employees Thursday that their experimental Covid-19 vaccine
wouldn't be influenced by politics, two days after President Trump
mentioned the company during the debate.
Chief Executive Albert Bourla sent a letter to all employees
saying Pfizer "would never succumb to political pressure" as it
develops a Covid-19 vaccine.
"The only pressure we feel -- and it weighs heavy -- are the
billions of people, millions of businesses and hundreds of
government officials that are depending on us," he wrote in the
letter, which was reviewed by The Wall Street Journal.
President Trump said in the presidential debate Tuesday that he
had spoken to Pfizer and a Covid-19 vaccine would be generally
available sooner than next summer, as suggested by federal health
officials. Mr. Trump said he disagreed with them.
The president's comments at the debate, as well as remarks
beforehand saying he sought a vaccine's authorization before
Election Day, have touched off partisan fighting over whether his
administration would push for a vaccine's use before it has been
fully vetted.
They come as surveys show significant numbers of Americans
harbor concerns about taking a vaccine, partly out of fear a shot
might be unsafe.
Pfizer is recruiting 44,000 people in more than 100 countries to
test its vaccine in a late-stage study. Dr. Bourla has said in
public appearances that the company could know results about
whether it works as early as this month.
Mr. Bourla said in the letter that can't predict exactly when,
or if, the U.S. Food and Drug Administration would authorize the
company's vaccine, which Germany's BioNTech SE is also working
on.
"But I do know that the world will be safer if we stop talking
about the vaccines' delivery in political terms and focus instead
on a rigorous independent scientific evaluation and a robust
independent approval process," he wrote.
Write to Jared S. Hopkins at jared.hopkins@wsj.com
(END) Dow Jones Newswires
October 01, 2020 15:36 ET (19:36 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024